2AHUMADA C, SAENZ T, GARCIA D , et al . The Effects of a Triterpene Fraction Isolated from Crataegus MONOGYNA JAcq.On Different Acute Inflamemation Models in Rats and Mice. Leucocyte Migration and Phospholipase A2 Inhibition[J]. J Pharm Pharmacol(S0022-3573), 1997, 49(3) :329-331.
3BAHORUN T, GRESSIER B, TROTIN F, et al. Oxygen Species Scavenging Activity of Phenolic Extracts from Hawthorn Fresh Plant Organs and Pharma-Ceutical Preparation[J]. Arzneimittelforschung(S0004-4172), 1996 , 46(11) :1086-1089.
4BAHORUN T, AUMJAUDE , RAMPHUL H, et al . Phenolic Constituents and Antioxidant Capacities of Crataegus Monogyna (hawthorn) Callus Extracts[J]. Nahrung(S1521-3803), 2003 , 47(3) :191-198.
5SCHUSSLER M, HOLZL J , FRICKE U. Myocardial effects of Flavonoids from Crataegus Species[J]. Arzneimittelforschung(S0004-4172), 1995 , 45(8) :842-845.
6TASKOV M. On the Coronary and Cardiotonic Action of Crataemon[J]. Acta Physiol Pharmacol Bulg (S0323 - 9950),1997, 3(4) :53-57.
7RODDWING C, HENSEL H. Reaction of Local Myocardial Blood Flow in Nonanesthetized Dogs and Anesthetized Cats to the Oral and Parenteral Administration of a Crateagus Fraction (oligomere procyanidines)[J]. Arzneimittelforschung(S0004-4172),1997 ,47(7):1407-1410.
8VREWERSKI W, PIECHOCKI T, RYLSKI M, et al . Einige Pharmakologische Eigenschaften Der Aus Weisdorn ( Crataegus oxyacantha ) Isolierten Oligomeren Procyanidine[J]. Arzhelm, Forsch/ Drug Res(S0348-6672), 1971, 21(6):886-887.
9STEPKA W, WINTERS AD. A Survey of the Genus Crataegus for Hypotensive Activity[J]. Lioydia(S1229-1854), 1973, 36(4) :431-432.
10RODDEWIG C, HENSEL H. Reaktion Der Lokalen Myokardduurchblutung Von Wachen Hunden und Narkotisierten Katzen Auf Orale Und Parenterale App-likation Einer Crataegusfraktion (oligomere procyanidine )[J]. Arzneim, Forsch /Drug Res(S0348-6672), 1977 , 27:1407-1410.
二级参考文献39
1Ahumada C, Saenz T, Garcia D, et al. The effects of a triterpene fraction isolated from Crataegus monogyna Jacq. On different acute inflammation models in rats and mice. Leucocyte migration and phospholipase A2 inhibition. J Pharm Pharmacol, 1997, 49(3):329.
2Bahorun T, Gressier B, Trotin F, et al. Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparation.Arzneimittelforschung, 1996, 46(11):1086.
3Bahorun T, Aumjaud E, Ramphul H, et al. Phenolic constituents and antioxidant capacities of Crataegus monogyna(hawthorn)callus extracts.Nahrung, 2003, 47(3):191.
4Schussler M, Holzl J, Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung, 1995, 45(8):842.
5Taskov M. On the coronary and cardiotonic action of crataemon. Acta Physiol Pharmacol Bulg, 1997, 3(4):53.
6Roddwing C, Hensel H. Reaction of local myocardial blood flow in non-anesthetized dogs and anesthetized cats to the oral and parenteral administration of a Crateagus fraction (oligomere procyanidines). Arzneimittelforschung,1997,47(7):1407.
7VRewerski W, Piechocki T, Rylski M, et al. Einige pharmakologische eigenschaften der aus weisdorn(Crataegus oxyacantha)isolierten oligomeren procyanidine. Arzneim, Forsch/Drug Res, 1971, 21(6)886.
8Stepka W, winters A D. A survey of the genus Crataegus for hypotensive activity. Lioydia, 1973, 36(4):431.
9Roddewig C, Hensel H. Reaktion der lokalen Myokardduurchblutung von wachen hunden und narkotisierten katzen auf orale und parenterale applikation einer crataegusfraktion (oligomere procyanidine). Arzneim.-Forsch./Drug Res, 1977, 27:1407.
10Joseph G, Zhao Y, Klaus W. Pharmacologic action profile of crataegus extract in comparison to epinephrine, amirinone, milrinone and digoxin in the isolated perfused guinea pig heart. Arzneimittelforschung, 1995, 45(12):1261.
